市場調查報告書
商品編碼
1395955
心律調節器市場:規模、細分市場、份額、法規、報銷、程序、到 2033 年的預測Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
病態竇房結綜合徵,也稱為竇房結功能障礙,是一種導致多種心律不整的疾病。 病態竇房結症候群的主要原因是衝動產生受損、傳導異常或竇房結功能受損。 心臟傳導阻滯是由於房室結或希氏-浦肯野系統的傳導系統異常而導致從心房到心室的電傳導受阻或延遲。 心臟傳導阻滯依其嚴重程度分為一級、二級或三級。 病態竇房結症候群和心臟傳導阻滯可以用抗心律不整藥物治療,但更明確的治療方法是植入心臟節律器,這有助於維持規律的心跳。 老年患者對人工心律調節器的耐受性良好。 建議使用心房起搏器來治療除慢性心房顫動患者以外的所有患者的病態竇房結症候群和心臟傳導阻滯。
本報告深入探討了全球起搏器市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。
Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Pacemakers market for the year 2020 and beyond. Sick sinus syndrome also known sinus node dysfunction is a number of conditions causing arrhythmias. The major causes of sick sinus syndrome can be the failure of impulse generation, abnormal conduction or sinus node degradation. Heart block is an interruption or delay of electrical conduction from the atria to the ventricles due to conduction system abnormalities in the AV node or the His-Purkinje system. Heart block is classified into first degree, second degree and third degree heart block based on its severity. Sick sinus syndrome and heart block can be treated with antiarrhythmic medicines but a more reliable treatment is implantation of a cardiac pacemaker which helps in maintaining a regular heartbeat. Artificial pacemakers are well tolerated in elderly patients. Atrial based pacemakers are recommended for treatment of sick sinus syndrome and heart block in all the patients except those with chronic atrial fibrillation.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Pacemakers market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Biotronik SE & Co KG, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable